The expression levels and the differential expression of transforming growth factor-β receptors in dermatofibroma and dermatofibrosarcoma protuberans
Authors:
- 11 September 2005
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 154 (5) , 919-925
Abstract
Background Dermatofibroma (DF) and dermatofibrosarcoma protuberans (DFSP) are benign and intermediate malignant fibrotic dermal tumours, respectively. The contribution of transforming growth factor (TGF)‐β has been implicated in the progression of sclerosis in fibrotic diseases. Objectives To investigate the expression of TGF‐β receptors in these fibrotic tumours. Methods We examined the expression levels of TGF‐β type I and type II receptors (TGFβ‐RI and TGFβ‐RII) in DF and DFSP using in situ hybridization and immunohistochemical analysis. We also examined the expression of TGF‐β1 and collagen type I using immunohistochemical analysis. Results We detected strong expression of TGFβ‐RI and TGFβ‐RII on epidermis and epidermal appendages, moderate expression in vascular endothelial cells, smooth muscle cells and neural tissues, and weak expression in fibroblasts in normal skin sections. The expression levels of TGFβ‐RI and TGFβ‐RII were elevated in the tissue sections of DF in comparison with normal dermal sections using in situ hybridization and immunohistochemical staining. Furthermore, the expression of TGFβ‐RI and TGFβ‐RII was strong in spindle‐shaped cells around DF. The expression of TGFβ‐RI and TGFβ‐RII was decreased in DFSP in comparison with DF, and their expression was found to be homogeneous in each DFSP tumour cell. The staining for TGF‐β1 was found prominently on matrix and spindle‐shaped tumour cells of DF, and peripheral regions of DFSP. Weak expression of TGF‐β1 was found on normal skin or tumour cells in the central part of DFSP. Type I collagen expression was found on spindle‐shaped tumour cells in DF, but not in tumour cells of DFSP. Conclusions These results suggest the possibility that TGF‐β signalling may contribute to the fibrosis around DF, and that TGF‐β receptors may play important roles in TGF‐β signalling. The expression patterns of TGFβ‐RI and TGFβ‐RII may be helpful in distinguishing these diseases.Keywords
This publication has 29 references indexed in Scilit:
- Transforming Growth Factor-?? Type II Receptors and Smad Proteins in Follicular Thyroid TumorsThe Laryngoscope, 2000
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- Defects of TGF-β receptor signaling in mammary cell tumorigenesisJournal of Mammary Gland Biology and Neoplasia, 1996
- Mechanism of activation of the TGF-β receptorNature, 1994
- Cellular Benign Fibrous HistiocytomaAmerican Journal of Surgical Pathology, 1994
- Reduced Levels of Transforming Growth Factor‐beta Type I Receptor in Human Gastric CarcinomasJapanese Journal of Cancer Research, 1992
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- An Immunohistochemical Study of Dermatofibrosarcoma Protuberans Supports Its Fibroblastic Character and Contradicts Neuroectodermal or Histiocytic ComponentsThe American Journal of Dermatopathology, 1990
- Dermatofibrosarcoma ProtuberansInternational Journal of Dermatology, 1984
- Dermatofibrosarcoma protuberans with lymph node and pulmonary metastasesArchives of Dermatology, 1978